Transformational therapies for
respiratory infection and serious diseases

 

 

 

Transformational therapies for
respiratory infection and serious diseases

Our Pipeline

We are developing safe, effective Nitric Oxide-based formulations for the treatment of respiratory infections and serious diseases.

Our Commitment

We are committed to transform the way we treat respiratory illnesses and serious illnesses by developing first-in-class Nitric Oxide based treatments.

ABOUT AIT

We are an emerging therapeutics company developing transformational therapies for respiratory infections & serious illnesses. We are harnessing the power of Nitric Oxide molecule with our proprietary dosing and delivery system to address a significant unmet need in medicine.

RESEARCH AND DEVELOPMENT

Our treatment has been tested in several company sponsored Phase 2 clinical trials, including trials in bronchiolitis, Cystic Fibrosis and Non-tuberculosis Myobacterium (NTM).  We are rapidly advancing to bring our first-in-class treatment to patients in need.

INVESTOR RELATIONS

We are committed to create tremendous value inflection for our investors rapidly.

LATEST NEWS

PRESENTATION

AIT Therapeutics Transformational Therapies for Lung and Other Infections

PRESS RELEASE

June 14, 2017 – AIT Therapeutics Announces Appointment of Steve Lisi as Chief Executive Officer.

STOCK PRICE